Correlation Between Novo Nordisk and Rovsing AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Rovsing AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Rovsing AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Rovsing AS, you can compare the effects of market volatilities on Novo Nordisk and Rovsing AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Rovsing AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Rovsing AS.

Diversification Opportunities for Novo Nordisk and Rovsing AS

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Novo and Rovsing is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Rovsing AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rovsing AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Rovsing AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rovsing AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Rovsing AS go up and down completely randomly.

Pair Corralation between Novo Nordisk and Rovsing AS

Assuming the 90 days trading horizon Novo Nordisk AS is expected to generate 0.48 times more return on investment than Rovsing AS. However, Novo Nordisk AS is 2.06 times less risky than Rovsing AS. It trades about 0.03 of its potential returns per unit of risk. Rovsing AS is currently generating about 0.01 per unit of risk. If you would invest  67,026  in Novo Nordisk AS on August 25, 2024 and sell it today you would earn a total of  8,064  from holding Novo Nordisk AS or generate 12.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  Rovsing AS

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Rovsing AS 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Rovsing AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Rovsing AS displayed solid returns over the last few months and may actually be approaching a breakup point.

Novo Nordisk and Rovsing AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Rovsing AS

The main advantage of trading using opposite Novo Nordisk and Rovsing AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Rovsing AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rovsing AS will offset losses from the drop in Rovsing AS's long position.
The idea behind Novo Nordisk AS and Rovsing AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets